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Background
Incidence of Type 2 diabetes mellitus (T2DM) in chil-
dren is rising alongside childhood obesity. In children,
there is limited therapeutic options and tight blood glu-
cose (BG) control may be challenging.
Aims
To determine metabolic control and complications in
children with T2DM seen in University Malaya Medical
Centre (UMMC).
Methods
Data on children with T2DM referred to and managed
in UMMC from 2000 until 2013 were collected. Their
body mass index (BMI and blood tests (HbA1c and
Lipids) were compared at presentation to their latest
clinic appointment. Treatment modalities and duration
of follow up were documented. T2DM was dignosed if
they had hyperglycaemia (Random BG > 11.8mmol/L or
fasting BG > 7mmol/L or 2hpp OGTT >11.1mmol/L
with low C-Peptide). Hypertension (HPT) if BP> 90th
centile for age,sex and height. Dyslipidemia is consid-
ered if either triglycerides> 1.7mmol/L, cholesterol
>5.2mmol/L, HDL< 1.03mmol/L or LDL> 2.50mmol/L.
Non-alcoholic fatty liver disease (NAFLD) was con-
firmed with ultrasound, diabetic nephropathy (DN) if
urine microalbumin>3.5 in boys , >4.5 in girls and dia-
betes retinopathy(DR) if reported by opthalmologist.
Results
A total of 49 children with T2DM were seen, but only
37 had available data for analysis. Their age ranged from
7-17 years old at initial presentation. Forty nine percent
(n=24) were boys. The mean duration for follow up was
3.6 years(0.2-10years).
Conclusions
This study revealed children with Type2DM had poor
metabolic control with mean HBAc of 9.7% and early
complications were already seen after 3.6 years of
follow up.
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Table 1
At presentation At last visit






28kgm2 (+2.62) 28.5kgm2 (+1.91)
Mean WC: 97.0cm 94.3 cm
Mean HbA1c: 11.2% (7.4-16%) 9.7% (5.4-14.4%)
Metformin: 56% (21/37) 92% (34/37)
Insulin: 32%(12/37)
** mainly due to ketosis
at diagnosis
32% (12/37)
** mainly due to poor BG
control
Dsylipidemia 92% (22/24 screened) 87% (21/24 screened)
Fatty Liver: Not screened at
diagnosis
80% (8/10 screened)
Nephropathy: Not screened at
diagnosis
24% (9/37)
Hypertension 24% (9/37) 8% (3/37)
Retinopathy: Not screened at
diagnosis
1 had early changes of
diabetes retinopathy
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